Projects per year
Fingerprint
Dive into the research topics where Benjamin A. Gartrell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM
Halmos, B., Gartrell, B. A., Rapkin, B. D., Einstein, M. H. & Sparano, J. A.
8/1/14 → 7/31/24
Project: Research project
-
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN
Shen, J., Chowdhury, S., Agarwal, N., Karsh, L. I., Oudard, S., Gartrell, B. A., Feyerabend, S., Saad, F., Pieczonka, C. M., Chi, K. N., Brookman-May, S. D., Rooney, B., Bhaumik, A., McCarthy, S. A., Bevans, K. B., Mundle, S. D., Small, E. J., Smith, M. R. & Graff, J. N., Jan 31 2024, In: British Journal of Cancer. 130, 1, p. 73-81 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer
Inman, B. A., Hahn, N. M., Stratton, K., Kopp, R., Sankin, A., Skinner, E., Pohar, K., Gartrell, B. A., Pham, S., Rishipathak, D., Mariathasan, S., Davarpanah, N., Carter, C. & Steinberg, G. D., Jun 1 2023, In: European urology oncology. 6, 3, p. 313-320 8 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results from phase II study, BTCRC-GU15-023
Joshi, M., Tuanquin, L., Zhu, J., Walter, V., Schell, T., Kaag, M., Kilari, D., Liao, J., Holder, S. L., Emamekhoo, H., Sankin, A., Merrill, S., Zheng, H., Warrick, J., Hauke, R., Gartrel, B., Stein, M., Drabick, J., Degraff, D. J. & Zakharia, Y., Feb 23 2023, In: Journal for ImmunoTherapy of Cancer. 11, 2, e006551.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men with Suspected Prostate Cancer Recurrence: Results from a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
Jani, A. B., Ravizzini, G. C., Gartrell, B. A., Siegel, B. A., Twardowski, P., Saltzstein, D., Fleming, M. T., Chau, A., Davis, P., Chapin, B. F. & Schuster, D. M., Sep 1 2023, In: Journal of Urology. 210, 3, p. 411-412 2 p.Research output: Contribution to journal › Comment/debate › peer-review
2 Scopus citations -
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Jani, A. B., Ravizzini, G. C., Gartrell, B. A., Siegel, B. A., Twardowski, P., Saltzstein, D., Fleming, M. T., Chau, A., Davis, P., Chapin, B. F., Schuster, D. M., Allaf, M., Avery, R. J., Avril, N., Barker, H., Belkoff, L., Bostrom, P., Cher, M. L., Chisholm, D., Covington, M. F., & 29 others , Aug 1 2023, In: Journal of Urology. 210, 2, p. 299-311 13 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations